Clinical Research Study to Learn About the Effect and Safety of Different Doses of FE 999302 When Given as a Single Dose for Final Development of the Eggs After Ovarian Stimulation

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The primary purpose of this trial is to compare three different doses of FE 999302 with 250 µg OVITRELLE and 10,000 IU NOVAREL on oocyte maturity when administered as a single dose for final development of the oocytes in women undergoing controlled ovarian stimulation.
Epistemonikos ID: 57380b2df2b5d056328855e2982e45bb606fba72
First added on: May 14, 2024